Area of research
Molecular Biology · Oncology
Research interest
Research interests include Medicine, Internal medicine, Meta-analysis, Anastomosis, Surgery, and Capecitabine.
Safety and efficacy of TQB2102, a novel bispecific anti-HER2 antibody–drug conjugate, in patients with advanced solid tumors: Preliminary data from the first-in-human phase 1 trial.
Phase III trial of metronomic capecitabine maintenance after standard treatment in operable triple-negative breast cancer (SYSUCC-001).
Mechanical versus Hand-Sewn Venous Anastomoses in Free Flap Reconstruction: A Systematic Review and Meta-Analysis
Measurement and Evaluation of Quantitative Performance of PET/CT Images before a Multicenter Clinical Trial